Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.77B
-
Number of holders
-
3021
-
Total 13F shares, excl. options
-
1.22B
-
Shares change
-
-11.8M
-
Total reported value, excl. options
-
$164B
-
Value change
-
-$1.67B
-
Put/Call ratio
-
0.7
-
Number of buys
-
1212
-
Number of sells
-
-1596
-
Price
-
$134.73
Significant Holders of AbbVie Inc. - Common Stock (ABBV) as of Q2 2023
3,325 filings reported holding ABBV - AbbVie Inc. - Common Stock as of Q2 2023.
AbbVie Inc. - Common Stock (ABBV) has 3,021 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.22B shares
of 1.77B outstanding shares and own 68.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (159M shares), BlackRock Inc. (139M shares), STATE STREET CORP (78.2M shares), JPMORGAN CHASE & CO (56.8M shares), Capital International Investors (43.2M shares), GEODE CAPITAL MANAGEMENT, LLC (35M shares), Capital Research Global Investors (32.5M shares), MORGAN STANLEY (31.3M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (22.8M shares), and NORTHERN TRUST CORP (21.4M shares).
This table shows the top 3021 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.